VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

Portable unbuzzd™ Single-Use Powder Sticks in Convenient 8-Pack Display Boxes Now Available for US Retailers TORONTO, March ...

Fidelity Investments is preparing to launch a US dollar-pegged stablecoin and an Ethereum-based share class for its US dollar ...

Follow live updates from the Spring Statement as Chancellor Rachel Reeves provides an update on the state of Britain's ...

Innovative solutions are essential for success in the fast-paced world of trading, where information can make or break an ...

Data is a stock trader''s secret weapon, providing the insights needed to develop strategies, manage risk, and drive informed ...

The new model, DeepSeek-V3-0324, is available through the AI development platform Hugging Face as part of the company’s ...

Upstart Holdings, Inc. UPST has been on a rollercoaster ride so far in 2025. Despite delivering back-to-back quarters of ...

Explore how AI, blockchain, and big tech are revolutionizing sports betting with smarter, faster, and more secure platforms ...

After soaring in 2023 and 2024, shares of Tesla (NASDAQ:TSLA) have been battered for nearly three months now. Since the start ...

Xero and FreshBooks are two great accounting platforms. But which is better for your business? We let you know.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.